vs
National Storage Affiliates Trust（NSA）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是National Storage Affiliates Trust的1.2倍（$219.9M vs $187.0M），National Storage Affiliates Trust净利率更高（12.2% vs -1.0%，领先13.3%），Orthofix Medical Inc.同比增速更快（2.0% vs -1.6%），National Storage Affiliates Trust自由现金流更多（$299.8M vs $16.8M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -2.4%）
National Storage Affiliates Trust是一家总部位于美国的房地产投资信托，专注于自助仓储资产，在美国数十个州持有、运营及收购自助仓储设施，为居民和商业客户提供安全的存储服务。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
NSA vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.2倍
$187.0M
营收增速更快
OFIX
高出3.6%
-1.6%
净利率更高
NSA
高出13.3%
-1.0%
自由现金流更多
NSA
多$283.0M
$16.8M
两年增速更快
OFIX
近两年复合增速
-2.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $187.0M | $219.9M |
| 净利润 | $22.9M | $-2.2M |
| 毛利率 | 72.5% | 71.1% |
| 营业利润率 | 20.2% | 0.2% |
| 净利率 | 12.2% | -1.0% |
| 营收同比 | -1.6% | 2.0% |
| 净利润同比 | 36.8% | 92.4% |
| 每股收益（稀释后） | $0.23 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NSAOFIX
| Q4 25 | $187.0M | $219.9M | ||
| Q3 25 | $188.7M | $205.6M | ||
| Q2 25 | $188.8M | $203.1M | ||
| Q1 25 | $188.4M | $193.6M | ||
| Q4 24 | $190.1M | $215.7M | ||
| Q3 24 | $193.6M | $196.6M | ||
| Q2 24 | $190.4M | $198.6M | ||
| Q1 24 | $196.1M | $188.6M |
净利润NSAOFIX
| Q4 25 | $22.9M | $-2.2M | ||
| Q3 25 | $18.4M | $-22.8M | ||
| Q2 25 | $19.5M | $-14.1M | ||
| Q1 25 | $13.0M | $-53.1M | ||
| Q4 24 | $16.7M | $-29.1M | ||
| Q3 24 | $18.7M | $-27.4M | ||
| Q2 24 | $17.1M | $-33.4M | ||
| Q1 24 | $59.0M | $-36.0M |
毛利率NSAOFIX
| Q4 25 | 72.5% | 71.1% | ||
| Q3 25 | 70.7% | 72.2% | ||
| Q2 25 | 70.5% | 68.7% | ||
| Q1 25 | 70.7% | 62.8% | ||
| Q4 24 | 72.5% | 69.0% | ||
| Q3 24 | 72.8% | 68.7% | ||
| Q2 24 | 72.6% | 67.8% | ||
| Q1 24 | 72.1% | 67.5% |
营业利润率NSAOFIX
| Q4 25 | 20.2% | 0.2% | ||
| Q3 25 | 15.8% | -8.3% | ||
| Q2 25 | 16.5% | -7.9% | ||
| Q1 25 | 11.0% | -25.2% | ||
| Q4 24 | 14.5% | -5.3% | ||
| Q3 24 | 15.8% | -9.6% | ||
| Q2 24 | 17.2% | -12.5% | ||
| Q1 24 | 48.9% | -15.6% |
净利率NSAOFIX
| Q4 25 | 12.2% | -1.0% | ||
| Q3 25 | 9.8% | -11.1% | ||
| Q2 25 | 10.3% | -6.9% | ||
| Q1 25 | 6.9% | -27.4% | ||
| Q4 24 | 8.8% | -13.5% | ||
| Q3 24 | 9.7% | -13.9% | ||
| Q2 24 | 9.0% | -16.8% | ||
| Q1 24 | 30.1% | -19.1% |
每股收益（稀释后）NSAOFIX
| Q4 25 | $0.23 | $-0.05 | ||
| Q3 25 | $0.17 | $-0.57 | ||
| Q2 25 | $0.19 | $-0.36 | ||
| Q1 25 | $0.10 | $-1.35 | ||
| Q4 24 | $0.19 | $-0.76 | ||
| Q3 24 | $0.18 | $-0.71 | ||
| Q2 24 | $0.16 | $-0.88 | ||
| Q1 24 | $0.65 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $23.3M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $946.0M | $450.0M |
| 总资产 | $5.1B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NSAOFIX
| Q4 25 | $23.3M | $82.0M | ||
| Q3 25 | $26.3M | $62.9M | ||
| Q2 25 | $26.1M | $65.6M | ||
| Q1 25 | $19.3M | $58.0M | ||
| Q4 24 | $50.4M | $83.2M | ||
| Q3 24 | $69.9M | $30.1M | ||
| Q2 24 | $59.0M | $26.4M | ||
| Q1 24 | $64.2M | $27.0M |
总债务NSAOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益NSAOFIX
| Q4 25 | $946.0M | $450.0M | ||
| Q3 25 | $973.1M | $442.5M | ||
| Q2 25 | $1.0B | $458.3M | ||
| Q1 25 | $1.0B | $458.3M | ||
| Q4 24 | $1.1B | $503.1M | ||
| Q3 24 | $986.9M | $525.9M | ||
| Q2 24 | $1.2B | $546.0M | ||
| Q1 24 | $1.3B | $570.3M |
总资产NSAOFIX
| Q4 25 | $5.1B | $850.6M | ||
| Q3 25 | $5.1B | $832.6M | ||
| Q2 25 | $5.2B | $837.2M | ||
| Q1 25 | $5.3B | $823.1M | ||
| Q4 24 | $5.4B | $893.3M | ||
| Q3 24 | $5.4B | $867.9M | ||
| Q2 24 | $5.3B | $882.0M | ||
| Q1 24 | $5.4B | $906.0M |
负债/权益比NSAOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $338.5M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $299.8M | $16.8M |
| 自由现金流率自由现金流/营收 | 160.3% | 7.6% |
| 资本支出强度资本支出/营收 | 20.7% | 4.9% |
| 现金转化率经营现金流/净利润 | 14.79× | — |
| 过去12个月自由现金流最近4个季度 | $541.5M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流NSAOFIX
| Q4 25 | $338.5M | $27.7M | ||
| Q3 25 | $100.2M | $12.4M | ||
| Q2 25 | $79.9M | $11.6M | ||
| Q1 25 | $85.6M | $-18.4M | ||
| Q4 24 | $363.1M | $23.7M | ||
| Q3 24 | $105.7M | $11.7M | ||
| Q2 24 | $83.2M | $9.0M | ||
| Q1 24 | $94.0M | $-18.6M |
自由现金流NSAOFIX
| Q4 25 | $299.8M | $16.8M | ||
| Q3 25 | $88.0M | $2.5M | ||
| Q2 25 | $73.8M | $4.5M | ||
| Q1 25 | $79.9M | $-25.1M | ||
| Q4 24 | $344.4M | $15.2M | ||
| Q3 24 | $101.8M | $6.3M | ||
| Q2 24 | $79.5M | $-360.0K | ||
| Q1 24 | $88.6M | $-29.1M |
自由现金流率NSAOFIX
| Q4 25 | 160.3% | 7.6% | ||
| Q3 25 | 46.6% | 1.2% | ||
| Q2 25 | 39.1% | 2.2% | ||
| Q1 25 | 42.4% | -13.0% | ||
| Q4 24 | 181.2% | 7.0% | ||
| Q3 24 | 52.6% | 3.2% | ||
| Q2 24 | 41.7% | -0.2% | ||
| Q1 24 | 45.2% | -15.4% |
资本支出强度NSAOFIX
| Q4 25 | 20.7% | 4.9% | ||
| Q3 25 | 6.5% | 4.8% | ||
| Q2 25 | 3.2% | 3.5% | ||
| Q1 25 | 3.0% | 3.5% | ||
| Q4 24 | 9.8% | 4.0% | ||
| Q3 24 | 2.0% | 2.7% | ||
| Q2 24 | 1.9% | 4.7% | ||
| Q1 24 | 2.7% | 5.6% |
现金转化率NSAOFIX
| Q4 25 | 14.79× | — | ||
| Q3 25 | 5.44× | — | ||
| Q2 25 | 4.10× | — | ||
| Q1 25 | 6.59× | — | ||
| Q4 24 | 21.70× | — | ||
| Q3 24 | 5.65× | — | ||
| Q2 24 | 4.88× | — | ||
| Q1 24 | 1.59× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NSA
暂无分部数据
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
